Loss of IL-10 decreases mouse postpubertal mammary gland development in the absence of inflammation

Immunol Invest. 2012;41(5):521-37. doi: 10.3109/08820139.2012.684193. Epub 2012 May 17.

Abstract

IL-10 is a pleiotrophic anti-inflammatory cytokine. Decreased IL-10 expression is associated with an increased breast cancer risk but the mechanism is not clear. This study was designed to test the hypothesis that the loss of IL-10 alters mammary development, even in the absence of inflammation. Wild-type and IL-10-/- mouse littermates were similar in growth, development, and breeding success. Using whole-mounts and paraffin sections, mammary glands from pre-pubertal mice (d21) were found to not be affected by the IL-10 null genotype. However, after the onset of estrous cycling, ductal structure, but not lymph nodes or adipocytes, of IL-10 knockout mice were found to moderately decrease at day 55, 80, and 150 of age. This phenotype was not rescued by lactogenesis. At day 2 of lactation, IL-10 null mice had reduced lobular complexity and glandular area with the retention of adipocytes. These results support the hypothesis that absence of IL-10 reduces glandular development during postnatal development, at maturity, and during the early stages of lactation. Although our study cannot distinguish between a direct IL-10 effect on the epithelial cells and an indirect systemic effect, epithelial cell responses to IL-10 should be considered in the therapeutic applications of cytokines or cytokine ablation.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Epithelial Cells / cytology
  • Female
  • Inflammation
  • Interleukin-10 / deficiency*
  • Interleukin-10 / genetics
  • Mammary Glands, Animal / growth & development*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Puberty / physiology

Substances

  • Interleukin-10